Bifurcation Lesions Market Trend Analysis, Industry Growth Rate, Company Profiles with Strategies 2028

No comments

IMARC Group has recently released a new research study titled “Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

How big is the bifurcation lesions market?

The global bifurcation lesions market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

Industry Overview: 

A bifurcation lesions refers to the constriction of the coronary artery near the origin of a substantial side branch (SB). This condition tends to develop atherosclerotic plaque owing to turbulent blood flow and high shear stress. Treatment for bifurcation lesions involves techniques such as analysis, procedure duration, X-ray exposure, and long-term follow-up. Three-dimensional (3D) angiography and multi-slice computed tomography are utilized to measure the angles of the bifurcation. advancements in devices, imaging techniques, adjunctive pharmacotherapy, and vascular access have made it feasible to manage complex cases of bifurcation lesions on a global scale.

Request to Get a Free Sample Report: https://www.imarcgroup.com/bifurcation-lesions-market/requestsample

Bifurcation Lesions Market Trends: 

The bifurcation lesions market is primarily driven by the increasing prevalence of coronary artery disease (CAD), the elevating approval of innovative devices, and advancements in imaging modalities. Furthermore, the market growth is also positively influenced by the expanding elderly population, who are more susceptible to medical conditions, and the introduction of favorable government initiatives to provide reimbursement.

Apart from this, the rising medical tourism segment, the emerging trend of minimally invasive procedures, and the escalating improvements in healthcare infrastructure are acting as significant growth-inducing factors.

Other Post You May Be Interested In

Moreover, the inflating investments in research and development (R&D) activities for novel treatments, including the Szabo 2-stent technique for complex bifurcation lesions with a high risk of side branch occlusion, the launch of various clinical trials on stents and balloons, along with the growing number of skilled healthcare professionals, which helps mitigate the risks associated with bifurcation lesion treatment will continue to catalyze the bifurcation lesions market in the coming years.

Competitive Landscape with Key Players:

The competitive landscape of the global bifurcation lesions market has been studied in the report with the detailed profiles of the key players operating in the market.

List of Bifurcation Lesions Key Companies Covered in this Market Report:

  • Boston Scientific Corporation
  • Cardinal Health
  • Medtronic plc
  • Spectranetics (Koninklijke Philips N.V.)
  • Terumo Corporation

Key Market Segmentation:

The report has segmented the global bifurcation lesions market on the basis of types, application and region.

Based on Types:

  • One-Stent
  • Two-Stent

Based on Application:

  • Coronary Vascular
  • Peripheral Vascular

Geographical Analysis:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore Full Report Description At: https://www.imarcgroup.com/bifurcation-lesions-market

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com

 

SHARE NOW

Leave a Reply

Your email address will not be published. Required fields are marked *